# POTASSIUM CITRATE EXTENDED RELEASE

NDC: 42543-406
Generic name: POTASSIUM CITRATE
Labeler / Manufacturer: Strides Pharma Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20171101

FDA application: ANDA206813

## Active ingredients

- POTASSIUM CITRATE: 5 meq/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"42543-406"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42543-406
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5f38b02c-703c-4fc2-b833-654e41bd617f